Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer

Moe Watanabe, Michiko Narita, Yusuke Hamada, Akira Yamashita, Hideki Tamura, Daigo Ikegami, Takashige Kondo, Tatsuto Shinzato, Takatsune Shimizu, Yumi Fukuchi, Akihiro Muto, Hideyuki Okano, Akihiro Yamanaka, Vivianne L. Tawfik, Naoko Kuzumaki, Edita Navratilova, Frank Porreca, Minoru Narita

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Chronic pain induced by nerve damage due to trauma or invasion of cancer to the bone elicits severe ongoing pain as well as hyperalgesia and allodynia likely reflecting adaptive changes within central circuits that amplify nociceptive signals. The present study explored the possible contribution of the mesolimbic dopaminergic circuit in promoting allodynia related to neuropathic and cancer pain. Mice with ligation of the sciatic nerve or treated with intrafemoral osteosarcoma cells showed allodynia to a thermal stimulus applied to the paw on the injured side. Patch clamp electrophysiology revealed that the intrinsic neuronal excitability of ventral tegmental area (VTA) dopamine neurons projecting to the nucleus accumbens (N.Acc.) was significantly reduced in those mice. We used tyrosine hydroxylase (TH)-cre mice that were microinjected with adeno-associated virus (AAV) to express channelrhodopsin-2 (ChR2) to allow optogenetic stimulation of VTA dopaminergic neurons in the VTA or in their N.Acc. terminals. Optogenetic activation of these cells produced a significant but transient anti-allodynic effect in nerve injured or tumor-bearing mice without increasing response thresholds to thermal stimulation in sham-operated animals. Suppressed activity of mesolimbic dopaminergic neurons is likely to contribute to decreased inhibition of N.Acc. output neurons and to neuropathic or cancer pain-induced allodynia suggesting strategies for modulation of pathological pain states.

Original languageEnglish (US)
JournalMolecular Pain
Volume14
DOIs
StatePublished - Jan 1 2018

Fingerprint

Bone Neoplasms
Ventral Tegmental Area
Dopaminergic Neurons
Hyperalgesia
Nucleus Accumbens
Optogenetics
Wounds and Injuries
Neuralgia
Hot Temperature
Pain
Dependovirus
Electrophysiology
Tyrosine 3-Monooxygenase
Sciatic Nerve
Osteosarcoma
Chronic Pain
Ligation
Neurons
Neoplasms

Keywords

  • cancer pain
  • dopamine
  • mesolimbic dopaminergic neurons
  • Neuropathic pain
  • optogenetics

ASJC Scopus subject areas

  • Molecular Medicine
  • Cellular and Molecular Neuroscience
  • Anesthesiology and Pain Medicine

Cite this

Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer. / Watanabe, Moe; Narita, Michiko; Hamada, Yusuke; Yamashita, Akira; Tamura, Hideki; Ikegami, Daigo; Kondo, Takashige; Shinzato, Tatsuto; Shimizu, Takatsune; Fukuchi, Yumi; Muto, Akihiro; Okano, Hideyuki; Yamanaka, Akihiro; Tawfik, Vivianne L.; Kuzumaki, Naoko; Navratilova, Edita; Porreca, Frank; Narita, Minoru.

In: Molecular Pain, Vol. 14, 01.01.2018.

Research output: Contribution to journalArticle

Watanabe, M, Narita, M, Hamada, Y, Yamashita, A, Tamura, H, Ikegami, D, Kondo, T, Shinzato, T, Shimizu, T, Fukuchi, Y, Muto, A, Okano, H, Yamanaka, A, Tawfik, VL, Kuzumaki, N, Navratilova, E, Porreca, F & Narita, M 2018, 'Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer', Molecular Pain, vol. 14. https://doi.org/10.1177/1744806918756406
Watanabe, Moe ; Narita, Michiko ; Hamada, Yusuke ; Yamashita, Akira ; Tamura, Hideki ; Ikegami, Daigo ; Kondo, Takashige ; Shinzato, Tatsuto ; Shimizu, Takatsune ; Fukuchi, Yumi ; Muto, Akihiro ; Okano, Hideyuki ; Yamanaka, Akihiro ; Tawfik, Vivianne L. ; Kuzumaki, Naoko ; Navratilova, Edita ; Porreca, Frank ; Narita, Minoru. / Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer. In: Molecular Pain. 2018 ; Vol. 14.
@article{0ca9c6a933cd4bd89cddc35ba5801953,
title = "Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer",
abstract = "Chronic pain induced by nerve damage due to trauma or invasion of cancer to the bone elicits severe ongoing pain as well as hyperalgesia and allodynia likely reflecting adaptive changes within central circuits that amplify nociceptive signals. The present study explored the possible contribution of the mesolimbic dopaminergic circuit in promoting allodynia related to neuropathic and cancer pain. Mice with ligation of the sciatic nerve or treated with intrafemoral osteosarcoma cells showed allodynia to a thermal stimulus applied to the paw on the injured side. Patch clamp electrophysiology revealed that the intrinsic neuronal excitability of ventral tegmental area (VTA) dopamine neurons projecting to the nucleus accumbens (N.Acc.) was significantly reduced in those mice. We used tyrosine hydroxylase (TH)-cre mice that were microinjected with adeno-associated virus (AAV) to express channelrhodopsin-2 (ChR2) to allow optogenetic stimulation of VTA dopaminergic neurons in the VTA or in their N.Acc. terminals. Optogenetic activation of these cells produced a significant but transient anti-allodynic effect in nerve injured or tumor-bearing mice without increasing response thresholds to thermal stimulation in sham-operated animals. Suppressed activity of mesolimbic dopaminergic neurons is likely to contribute to decreased inhibition of N.Acc. output neurons and to neuropathic or cancer pain-induced allodynia suggesting strategies for modulation of pathological pain states.",
keywords = "cancer pain, dopamine, mesolimbic dopaminergic neurons, Neuropathic pain, optogenetics",
author = "Moe Watanabe and Michiko Narita and Yusuke Hamada and Akira Yamashita and Hideki Tamura and Daigo Ikegami and Takashige Kondo and Tatsuto Shinzato and Takatsune Shimizu and Yumi Fukuchi and Akihiro Muto and Hideyuki Okano and Akihiro Yamanaka and Tawfik, {Vivianne L.} and Naoko Kuzumaki and Edita Navratilova and Frank Porreca and Minoru Narita",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1744806918756406",
language = "English (US)",
volume = "14",
journal = "Molecular Pain",
issn = "1744-8069",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer

AU - Watanabe, Moe

AU - Narita, Michiko

AU - Hamada, Yusuke

AU - Yamashita, Akira

AU - Tamura, Hideki

AU - Ikegami, Daigo

AU - Kondo, Takashige

AU - Shinzato, Tatsuto

AU - Shimizu, Takatsune

AU - Fukuchi, Yumi

AU - Muto, Akihiro

AU - Okano, Hideyuki

AU - Yamanaka, Akihiro

AU - Tawfik, Vivianne L.

AU - Kuzumaki, Naoko

AU - Navratilova, Edita

AU - Porreca, Frank

AU - Narita, Minoru

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chronic pain induced by nerve damage due to trauma or invasion of cancer to the bone elicits severe ongoing pain as well as hyperalgesia and allodynia likely reflecting adaptive changes within central circuits that amplify nociceptive signals. The present study explored the possible contribution of the mesolimbic dopaminergic circuit in promoting allodynia related to neuropathic and cancer pain. Mice with ligation of the sciatic nerve or treated with intrafemoral osteosarcoma cells showed allodynia to a thermal stimulus applied to the paw on the injured side. Patch clamp electrophysiology revealed that the intrinsic neuronal excitability of ventral tegmental area (VTA) dopamine neurons projecting to the nucleus accumbens (N.Acc.) was significantly reduced in those mice. We used tyrosine hydroxylase (TH)-cre mice that were microinjected with adeno-associated virus (AAV) to express channelrhodopsin-2 (ChR2) to allow optogenetic stimulation of VTA dopaminergic neurons in the VTA or in their N.Acc. terminals. Optogenetic activation of these cells produced a significant but transient anti-allodynic effect in nerve injured or tumor-bearing mice without increasing response thresholds to thermal stimulation in sham-operated animals. Suppressed activity of mesolimbic dopaminergic neurons is likely to contribute to decreased inhibition of N.Acc. output neurons and to neuropathic or cancer pain-induced allodynia suggesting strategies for modulation of pathological pain states.

AB - Chronic pain induced by nerve damage due to trauma or invasion of cancer to the bone elicits severe ongoing pain as well as hyperalgesia and allodynia likely reflecting adaptive changes within central circuits that amplify nociceptive signals. The present study explored the possible contribution of the mesolimbic dopaminergic circuit in promoting allodynia related to neuropathic and cancer pain. Mice with ligation of the sciatic nerve or treated with intrafemoral osteosarcoma cells showed allodynia to a thermal stimulus applied to the paw on the injured side. Patch clamp electrophysiology revealed that the intrinsic neuronal excitability of ventral tegmental area (VTA) dopamine neurons projecting to the nucleus accumbens (N.Acc.) was significantly reduced in those mice. We used tyrosine hydroxylase (TH)-cre mice that were microinjected with adeno-associated virus (AAV) to express channelrhodopsin-2 (ChR2) to allow optogenetic stimulation of VTA dopaminergic neurons in the VTA or in their N.Acc. terminals. Optogenetic activation of these cells produced a significant but transient anti-allodynic effect in nerve injured or tumor-bearing mice without increasing response thresholds to thermal stimulation in sham-operated animals. Suppressed activity of mesolimbic dopaminergic neurons is likely to contribute to decreased inhibition of N.Acc. output neurons and to neuropathic or cancer pain-induced allodynia suggesting strategies for modulation of pathological pain states.

KW - cancer pain

KW - dopamine

KW - mesolimbic dopaminergic neurons

KW - Neuropathic pain

KW - optogenetics

UR - http://www.scopus.com/inward/record.url?scp=85050980339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050980339&partnerID=8YFLogxK

U2 - 10.1177/1744806918756406

DO - 10.1177/1744806918756406

M3 - Article

C2 - 29357732

AN - SCOPUS:85050980339

VL - 14

JO - Molecular Pain

JF - Molecular Pain

SN - 1744-8069

ER -